Send to a Friend Share

Brigantine Advisors maintains a 'Hold' on Zimmer Holdings (ZMH); Macro Headwinds Keep Us Neutral

January 26, 2011 9:36 AM EST
ZMH Hot Sheet
Rating Summary:
    9 Buy, 12 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 19 | Down: 16 | New: 82
Brigantine Advisors maintains a 'Hold' on Zimmer Holdings (NYSE: ZMH).

Brigantine analyst says, "With Biomet (Nasdaq: BMET), Johnson & Johnson (NYSE: JNJ) and Stryker (NYSE: SYK) already out with quarterly results, we have sufficient data points to confirm that softness in hip and knee procedures, combined with lower pricing and slow uptake of most premium priced new products will be a common theme across the orthopedics group in Q4."

"Zimmer will report Q4 results ahead of the market open on January 27. Full 2010 constant-currency revenue guidance of +2% implies Q4 of about $1.1B, flat Y/Y. We are inline at $1.1B and look for EPS of $1.18 vs. $1.17-$1.22 guidance. Consensus forecasts stand at $1.1B/$1.19."

For more ratings news on Zimmer Holdings click here and for the rating history of Zimmer Holdings click here.

Shares of Zimmer Holdings closed at $56.38 yesterday, with a 52 week range of $46.27-$62.50.


Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!

You May Also Be Interested In


Related Categories

Analyst Comments

Add Your Comment





Follow StreetInsider.com On Twitter